The Israeli global shipping company ZIM Integrated Shipping Services officially announced today (Monday) that the company's Board of Directors has appointed Dr. Chen Lichtenstein as the new President and CEO. The appointment follows the resignation of outgoing CEO Eli Glickman on April 15, 2026.
Dr. Lichtenstein's appointment will take effect on July 1, 2026, at which time he will also join the ZIM Board of Directors. The incoming CEO's employment agreement will be submitted for shareholder approval, in accordance with the requirements of the Israeli Companies Law.
Dr. Lichtenstein currently serves as a board member at Teva Pharmaceutical Industries, as Chairman of the Board for international companies in environmental sciences and biotechnology, and as a senior advisor to international investment bodies. He holds joint doctoral degrees (Law and Business Administration) from Stanford University in the US, and bachelor's degrees in Physics (cum laude) and Law from the Hebrew University of Jerusalem.
Dr. Lichtenstein's appointment was determined following a focused search process conducted by the ZIM Board, with the participation of Chairman Yair Seroussi and directors Dr. Yoram Turbowicz and Yair Avidan.
"The market is dynamic and complex - maintaining company stability is of paramount importance"
Yair Seroussi, Chairman of the ZIM Board of Directors, stated: "Dr. Chen Lichtenstein is a highly experienced, first-rate international executive with a unique combination of financial depth, strategic insight, and a proven ability to lead complex global organizations. His judgment and experience in leading transformation and integration processes make him the right manager to lead ZIM at this time. We thank Eli Glickman for his significant contribution to the company and wish Chen great success in his role."
Dr. Chen Lichtenstein, the incoming CEO of ZIM, noted: "I thank the ZIM Board for their trust and for the opportunity to lead a global Israeli company with a significant heritage, growth, and business success, extensive international operations, and excellent people. ZIM operates in a dynamic, competitive, and complex market, and I see supreme importance in maintaining the company's stability, strengthening its performance and business capabilities, and continuing to create value for our customers, employees, partners, and shareholders."
Rich international experience in global markets and investment banking
Dr. Lichtenstein brings extensive management, business, and financial experience in the international arena to ZIM, including leading complex global companies, managing growth processes, integration, and organizational changes in multinational markets.
Key Milestones in Lichtenstein's Career:
| Years | Role and Company | Key Milestones and Achievements |
|---|---|---|
| 2020–2023 | Chief Financial Officer (CFO) Syngenta Group |
Managed strategy and integration at the global agrotech giant, leading synergy initiatives and managing complex group debt structures. |
| 2014–2020 | President and CEO Adama Ltd. (formerly Makhteshim Agan) |
Led the company through significant growth, improved cash flow, merged operations with China's ChemChina, and listed on the Shenzhen Stock Exchange. |
| 2013–2014 | President and CEO CNAC (Agrochemical division of ChemChina) |
Managed the strategic division of the Chinese national chemical corporation and parent company of Syngenta. |
| 2006–2013 | Deputy CEO and Head of Global Operations Makhteshim Agan |
Managed and led Global Operations and international production for the company. |
| 1999–2006 | Senior Investment Banking Roles Goldman Sachs |
Operated in the company's New York and London offices, leading large-scale M&A and financing transactions. |
ZIM, founded in Israel in 1945, is one of the world's leading container shipping companies, with operations in over 90 countries, serving approximately 30,000 customers in more than 300 ports worldwide, and is traded on the New York Stock Exchange (NYSE).
